• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 950

Bifidobacterium longum subsp. infantis DSM 33361

Intended Use: For use as an ingredient in cow milk-, soy-, and partially hydrolyzed protein-based, non-exempt infant formula for term infants at a level up to 1 x 1010 colony forming units (CFU)/g, and in conventional foods, including but not limited to milk and dairy products; plant-based dairy alternatives; beverages; bars; confectionery; and cereals and at a use level up to 2.8 x 1010 CFU/serving.
Basis: Scientific procedures
Notifier: Chr. Hansen, Inc.
Notifier Address: 9015 West Maple Street
Milwaukee, WI 53214
GRAS Notice (releasable information): GRN 950 Part 1 (in PDF) (11.5 MB)
  Part 2: GRN 950 Part 2 (in PDF) (8.9 MB)
  Part 3: GRN 950 amendments (8.3 MB)
Date of closure: Mar 1, 2021
FDA's Letter: FDA has no questions (in PDF) (281 kB)